Document is current
Any future updates will be listed below
-
Authors
Bergmann, Jacob Siewertsen
Hamm, Sebastian Rask
Bering, Louise
Pedersen, Christian Ross
Bock, Ask
Heidari, Safura-Luise
Villadsen, Gerda Elisabeth
Fialla, Annette Dam
Willemoe, Gro Linno
Holland-Fischer, Peter
Nielsen, Susanne Dam
-
Funding
Funding for this research was provided by:
Research Foundation of Rigshospitalet
- License Information
-
More Information
Article History
Received: 15 April 2025
Accepted: 14 July 2025
First Online: 2 August 2025
Competing interests
: L.B., C.R.P., A.B., G.E.V., A.D.F., G.L.W., P.H.: No conflict of interest. J.S.B.: Received a research grant from Rigshospitalet related to this manuscript. S.R.H.: Received research grants from Rigshospitalet unrelated to this manuscript. S.L.H.: Received a scholarship grant from the Novo Nordisk Foundation and received a travel grant from GlaxoSmithKline, both unrelated to this manuscript. S.D.N.: Received unrestricted research grants from the Novo Nordisk Foundation, Svend Andersen Fonden, Kirsten og Freddy Johansens Fond, and the Independent Research Fund Denmark and reports advisory board activity for Gilead Sciences, Takeda, and GlaxoSmithKline/ViiV Healthcare, all unrelated to this manuscript.
